Michael Boe Møller

Medicin og biovidenskab

1. Lymphoma, Large B-Cell, Diffuse 100%
2. Lymphoma 32%
3. Rituximab 27%
4. Mutation 23%
5. Survival 23%
6. Systemic Mastocytosis 23%
7. B-Lymphocytes 22%
8. Non-Hodgkin's Lymphoma 19%
9. Mastocytosis 17%
10. Polycythemia Vera 12%
11. Neoplasms 10%
12. Vincristine 10%
13. Germinal Center 10%
14. Prednisone 10%
15. Essential Thrombocythemia 9%
16. Cyclophosphamide 9%
17. Bone Marrow 8%
18. Multiple Myeloma 8%
19. Core Binding Factors 8%
20. Genes 8%
21. Alleles 7%
22. Mantle-Cell Lymphoma 7%
23. Population 7%
24. Anaplastic Large-Cell Lymphoma 7%
25. B-Cell Lymphoma 7%
26. Transcriptome 7%
27. Anaphylaxis 7%
28. Peripheral T-Cell Lymphoma 7%
29. Immunohistochemistry 6%
30. Proteomics 6%
31. Cyclin D3 6%
32. T-Cell Lymphoma 6%
33. Gene Expression Profiling 6%
34. Proteins 6%
35. Acute Myeloid Leukemia 6%
36. Progression-Free Survival 6%
37. Myeloproliferative Disorders 6%
38. B-Cell Chronic Lymphocytic Leukemia 5%
39. Doxorubicin 5%
40. Therapeutics 5%
41. Mast Cells 5%
42. High-Throughput Nucleotide Sequencing 5%
43. Interferon alpha-2 5%
44. Primary Myelofibrosis 5%
45. T-Lymphocytes 5%
46. Biopsy 5%
47. Galectin 1 5%
48. Huntingtin Protein 5%
49. Multivariate Analysis 5%